My Mobile Advice Program: A Randomized Pilot Feasibility Study

Completed · Not applicable

Conditions studied: Smoking Cessation, Medication Adherence

In brief

The purpose of this pilot study is to evaluate the acceptability and feasibility of the proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program).

Key facts

Study ID

NCT02136498

Run by

Kaiser Permanente

People needed

66

Starts

2014-10-01

Expected to finish

2016-02-01

Last updated by the study team

2017-11-13

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• An invited member of Group Health, a health care system in the Pacific Northwest
• Plan to remain enrolled in Group Health for the next 6 months
• aged 18 - 65
• Eligible for smoking cessation treatment through Group Health insurance coverage
• smoke >= 10 cigs a day
• speak and read in English
• willing to use varenicline and no contraindications for this medication
• ready to quit smoking
• have a smart phone with internet access
• willing to receive study texts and emails
• receive care at a Group Health clinic and have electronic medical records in this system
• fill prescriptions through the Group Health pharmacy
• agree to use birth control while taking study medication, if there is a risk of pregnancy

You may not qualify if…

• lifetime history of dementia
• psychosis or bipolar disorder based on self-report or medical record review
• hearing, comprehension or visual limitations that preclude full study participation
• current use of other forms of tobacco
• any medical contraindication for varenicline use
• documented history of suicidal ideation/intent

Where it is running

• Group Health Research Institute — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.